Signaling Pathways
-
A1632 SB202190 (FHPI)5 CitationTarget: p38Summary: P38 MAPK inhibitor
-
A2552 Quercetin dihydrateTarget: PI3K|PIM1 kinase|phospholipase A2Summary: PLA2 and PI 3-kinase inhibitor
-
A1337 U0126-EtOH10 CitationTarget: MEKSummary: MEK1/2 inhibitor
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
-
A2213 17-DMAG (Alvespimycin) HCl1 CitationTarget: HSP90Summary: Hsp90 inhibitor
-
A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent
-
A1379 NelarabineSummary: Prodrug of ara-G for T-LBL/T-ALL
-
A5072 GSK690693Target: Akt|PKC|PKG|PKA|PrkSummary: Pan-AKT inhibitor,ATP-competitive and potent
-
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: HER2 inhibitor,potent and selective
-
A2251 Tivozanib (AV-951)Target: VEGFRSummary: VEGFR inhibitor,potent and selective